<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2011, p. 1982&#8211;1989                                                                      Vol. 55, No. 5 <br /> 0066-4804/11/$12.00 doi:10.1128/AAC.01796-10 <br /> Copyright &#169; 2011, American Society Microbiology. All Rights Reserved. <br />  <br />  <br />  <br />        Selective Inhibitors Methionyl-tRNA Synthetase Have Potent <br />            Activity <span id='am-154' about='obo:NCBITaxon_5690' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_5653'><span id='am-155' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-156'  ></span><span id='am-157' property="rdfs:label" content="Trypanosoma" datatype="xsd:string"></span><span id='am-158' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Trypanosoma</span> brucei Infection Mice&#17188;&#8224; <br />  Sayaka Shibata,1 J. Robert Gillespie,2 <span id='am-194' about='obo:NCBITaxon_444773' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_33154 obo:NCBITaxon_6656 obo:NCBITaxon_267072 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_7505 obo:NCBITaxon_6970 obo:NCBITaxon_7504 obo:NCBITaxon_33341 obo:NCBITaxon_50557 obo:NCBITaxon_6072 obo:NCBITaxon_6960'><span id='am-195' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-196'  ></span><span id='am-197' property="rdfs:label" content="Angela" datatype="xsd:string"></span><span id='am-198' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Angela</span> M. Kelley,2 Alberto J. Napuli,2 Zhongsheng Zhang,1 <br />     Kuzma V. Kovzun,2 Ranae M. Pefley,2 Jocelyn Lam,2 Frank H. Zucker,1 Wesley C. Van Voorhis,2 <br />                   Ethan A. Merritt,1 Wim G. J. Hol,1 Christophe L. M. J. Verlinde,1 <br />                              Erkang Fan,1 Frederick S. Buckner2* <br />           Department Biochemistry1 Department Medicine,2 University Washington, Seattle, Washington 98195 <br />                       Received 21 December 2010/Returned modification 19 January 2011/Accepted 24 January 2011 <br />  <br />              Human African trypanosomiasis continues important public health threat extensive regions of <br />           sub-Saharan Africa. Treatment options infected patients unsatisfactory toxicity, difficult ad- <br />           ministration regimes, poor efficacy available drugs. The aminoacyl-tRNA synthetases selected as <br />           attractive drug targets essential roles protein synthesis cell survival. Comparative sequence <br />           analysis disclosed differences trypanosome mammalian methionyl-tRNA synthetases <br />           (MetRSs) suggested opportunities selective inhibition using drug-like molecules. Experiments using <br />           RNA interference single MetRS <span id='am-159' about='obo:NCBITaxon_5691' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_39700 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_5690 obo:NCBITaxon_2759 obo:NCBITaxon_5653'><span id='am-160' property="oboInOwl:hasRelatedSynonym" content="Trypanosoma (Trypanozoon) brucei" datatype="xsd:string"></span><span id='am-161' property="rdfs:label" content="Trypanosoma brucei" datatype="xsd:string"></span><span id='am-162' property="oboInOwl:hasRelatedSynonym" content="Trypanosoma brucei subgroup" datatype="xsd:string"></span><span id='am-163' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-164'  ></span><span id='am-165' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Trypanosoma brucei</span> demonstrated gene product was <br />           essential normal cell growth. Small molecules (diaryl diamines) similar shown potent <br />           activity prokaryotic MetRS enzymes synthesized observed inhibitory activity T. <br />           brucei MetRS (50% inhibitory concentration, &lt;50 nM) bloodstream forms T. brucei cultures (50% <br />           effective concentration, low 4 nM). Twenty-one compounds close correlation enzyme <br />           binding/inhibition T. brucei growth inhibition, indicating likely acting intended <br />           target. The compounds minimal effects mammalian cell growth 20 &#65533;?&#65533;M, demonstrating wide <br />           therapeutic index. The potent compound tested murine model trypanosomiasis and <br />           demonstrated profound parasite suppression delayed mortality. A homology model T. brucei MetRS <br />           based MetRS structures used model binding lead diaryl diamine compounds. Future <br />           studies focus improving pharmacological properties MetRS inhibitors. <br />  <br />  <br />    Drugs meet modern standards chemotherapeutics                       sequences proteins. With notable exceptions (27), <br /> have, unfortunately, developed human African                   aaRS specifically recognize single amino acid and <br /> trypanosomiasis (HAT). The currently used drugs HAT                         attach corresponding tRNA anticodon matches <br /> include suramin (an injection drug introduced 1922),                         codons amino acid. The sequence <br /> melarsoprol (a highly toxic arsenical use 1949), pent-                 reactions catalyzed consists essential steps: (i) rec- <br /> amidine (introduced 1940s given painful intra-                    ognition correct amino acid, (ii) reaction ATP to <br /> muscular injections), eflornithine (introduced 1980s                 form aminoacyl-adenylate intermediate, (iii) recognition of <br /> given intravenously 6 h multigram quantities),                     cognate tRNA, (iv) transfer aminoacyl group to <br /> nifurtimox (a drug originally developed Chagas&#8217; disease                  terminal adenosine tRNA. Interference of <br /> the 1970s used combination eflornithine                     steps inhibits formation properly charged tRNA, <br /> HAT). With 60 million people Africa risk HAT,                     leading accumulation uncharged tRNA ribosome. <br /> need effective, safe, affordable drugs remains acute                 <span id='am-178' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-179' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-180'  ></span><span id='am-181' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-182' property="rdfs:label" content="This" datatype="xsd:string"></span>This</span> results disruption normal protein chain elongation <br /> as ever. The completion Trypanosoma brucei genome                        translation. Not surprisingly, aaRS enzymes been <br /> sequencing project combined advances modern drug                        shown essential genetic knockout knockdown stud- <br /> discovery techniques creates unprecedented opportunity                    ies variety organisms (3, 4, 10, 11). <br /> develop overdue, modern drugs lethal disease.                             T. brucei encodes 23 aaRS enzymes, amino acid, <br />    Analysis sequenced T. brucei genome reveals hun-                      exception 2 enzymes aspartate (4), 2 lysine <br /> dreds genes encoding enzymes, in-                      (8), 2 tryptophan (3). The methionyl-RS (MetRS) T. <br /> teresting drug development standpoint amino- <br />                                                                                 brucei particularly attracted signif- <br /> acyl-tRNA synthetases (aaRSs). These enzymes essential <br />                                                                                 icant differences mammalian orthologs (discussed <br /> to core biological process translating gene nucleotide <br />                                                                                 herein) existence compounds under <br />                                                                                 development Pharma targeting homologous enzyme in <br />    * Corresponding author. Mailing address: University Washington,           bacteria. MetRS enzymes general divided major <br /> Division Allergy Infectious Diseases, Box 357185, Seattle, WA            forms basis sequence similarity sensitivity to <br /> 98195. Phone: (206) 616-9214. Fax: (206) 685-6045. E-mail: fbuckner             inhibitors (3, 12). MetRS1 form commonly in <br /> @uw.edu. <br />    &#8224; Supplemental material article http://aac <br />                                                                                 Gram-positive bacteria, including <span id='am-1' about='obo:NCBITaxon_1279' typeof='obo:NCBITaxon_91061 owl:Thing obo:NCBITaxon_1385 obo:NCBITaxon_90964 obo:NCBITaxon_1239 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_2'><span id='am-2' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasDbXref" content="PMID:9734063" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasDbXref" content="PMID:12656157" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:hasDbXref" content="PMID:10425778" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasDbXref" content="PMID:10319469" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasRelatedSynonym" content="Aurococcus" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasDbXref" content="PMID:17220435" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="PMID:10319495" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasDbXref" content="PMID:10758876" datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="Staphylococcus" datatype="xsd:string"></span><span id='am-13'  ></span>Staphylococcus</span> aureus and <br /> .asm.org/.                                                                      <span id='am-28' about='obo:NCBITaxon_1301' typeof='obo:NCBITaxon_91061 owl:Thing obo:NCBITaxon_1239 obo:NCBITaxon_1 obo:NCBITaxon_1300 obo:NCBITaxon_131567 obo:NCBITaxon_2 obo:NCBITaxon_186826'><span id='am-29' property="rdfs:label" content="Streptococcus" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasDbXref" content="PMID:7537076" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasDbXref" content="PMID:8995803" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasDbXref" content="PMID:14657115" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasDbXref" content="PMID:10555340" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasDbXref" content="PMID:1720654" datatype="xsd:string"></span><span id='am-36'  ></span><span id='am-37' property="oboInOwl:hasDbXref" content="PMID:19620365" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Streptococcus</span> pyogenes. MetRS2 <span id='am-86' about='obo:NCBITaxon_2157' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567'><span id='am-87' property="oboInOwl:hasDbXref" content="PMID:10425796" datatype="xsd:string"></span><span id='am-88' property="oboInOwl:hasRelatedSynonym" content="Metabacteria" datatype="xsd:string"></span><span id='am-89' property="oboInOwl:hasDbXref" content="PMID:9336922" datatype="xsd:string"></span><span id='am-90' property="oboInOwl:hasRelatedSynonym" content="Mendosicutes" datatype="xsd:string"></span><span id='am-91' property="oboInOwl:hasDbXref" content="PMID:11411719" datatype="xsd:string"></span><span id='am-92' property="oboInOwl:hasDbXref" content="PMID:12054223" datatype="xsd:string"></span><span id='am-93' property="oboInOwl:hasDbXref" content="PMID:2112744" datatype="xsd:string"></span><span id='am-94' property="oboInOwl:hasDbXref" content="PMID:11211268" datatype="xsd:string"></span><span id='am-95' property="oboInOwl:hasRelatedSynonym" content="Prokaryotae" datatype="xsd:string"></span><span id='am-96' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-97' property="oboInOwl:hasDbXref" content="PMID:11321113" datatype="xsd:string"></span><span id='am-98' property="oboInOwl:hasDbXref" content="PMID:10939673" datatype="xsd:string"></span><span id='am-99' property="oboInOwl:hasDbXref" content="PMID:11541975" datatype="xsd:string"></span><span id='am-100' property="oboInOwl:hasRelatedSynonym" content="Archaebacteria" datatype="xsd:string"></span><span id='am-101' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-102' property="rdfs:label" content="Archaea" datatype="xsd:string"></span><span id='am-103' property="oboInOwl:hasDbXref" content="PMID:8123559" datatype="xsd:string"></span><span id='am-104' property="oboInOwl:hasDbXref" content="PMID:10490293" datatype="xsd:string"></span><span id='am-105' property="oboInOwl:hasDbXref" content="PMID:11542064" datatype="xsd:string"></span><span id='am-106' property="oboInOwl:hasRelatedSynonym" content="prokaryotes" datatype="xsd:string"></span><span id='am-107' property="oboInOwl:hasRelatedSynonym" content="Prokaryota" datatype="xsd:string"></span><span id='am-108' property="oboInOwl:hasDbXref" content="PMID:11321083" datatype="xsd:string"></span><span id='am-109' property="oboInOwl:hasDbXref" content="PMID:270744" datatype="xsd:string"></span><span id='am-110' property="oboInOwl:hasDbXref" content="PMID:10939677" datatype="xsd:string"></span><span id='am-111' property="oboInOwl:hasRelatedSynonym" content="prokaryote" datatype="xsd:string"></span><span id='am-112' property="oboInOwl:hasDbXref" content="PMID:11540071" datatype="xsd:string"></span><span id='am-113'  ></span><span id='am-114' property="oboInOwl:hasDbXref" content="PMID:10425797" datatype="xsd:string"></span><span id='am-115' property="oboInOwl:hasDbXref" content="PMID:10843050" datatype="xsd:string"></span><span id='am-116' property="oboInOwl:hasDbXref" content="PMID:10939651" datatype="xsd:string"></span><span id='am-117' property="oboInOwl:hasRelatedSynonym" content="Procaryotae" datatype="xsd:string"></span><span id='am-118' property="oboInOwl:hasRelatedSynonym" content="archaea" datatype="xsd:string"></span><span id='am-119' property="oboInOwl:hasDbXref" content="PMID:11760965" datatype="xsd:string"></span><span id='am-120' property="oboInOwl:hasDbXref" content="PMID:10425795" datatype="xsd:string"></span><span id='am-121' property="oboInOwl:hasRelatedSynonym" content="Monera" datatype="xsd:string"></span><span id='am-122' property="oboInOwl:hasDbXref" content="PMID:11542149" datatype="xsd:string"></span><span id='am-123' property="oboInOwl:hasDbXref" content="PMID:9103655" datatype="xsd:string"></span><span id='am-124' property="oboInOwl:hasDbXref" content="PMID:8590690" datatype="xsd:string"></span>archaea</span>, eu- <br />    &#17188; <br />      Published ahead print 31 January 2011.                               karyotes, Gram-negative bacteria. Eukaryotic organ- <br />  <br />                                                                          1982 <br />  VOL. 55, 2011                                                                   T. BRUCEI METHIONYL-tRNA SYNTHETASE INHIBITORS                                           1983 <br />  <br />  <br /> isms contain MetRS forms, MetRS1 mito-                            lowed size exclusion gel chromatography (Superdex 75 26/60; GE Biosciences, <br /> chondrial form MetRS2 cytoplasmic form. In                              Piscataway, NJ). <br />                                                                                          Thermal shift assay. The thermal shift assay performed previously de- <br /> mammals, mitochondrial aaRS enzymes encoded                            scribed (7), modifications samples contained MetRS enzyme (0.42 <br /> nucleus imported mitochondrion import signals.                         mg/ml T. brucei enzyme, 0.32 mg/ml T. cruzi enzyme), 50 &#65533;?&#65533;M inhibitor, <br /> The single MetRS T. brucei encoded nucleus                           10 mM ATP magnesium salt, 10 mM L-methionine, 5% dimethyl sulfoxide <br /> presumably functions cytoplasm mitochon-                          (DMSO). The inclusion 10 mM ATP methionine assay buffer to <br />                                                                                       suppress overall thermal shift signal tight-binding inhibitors could <br /> drion (26). On basis sequence, T. brucei MetRS <br />                                                                                       cause significant shift melting temperature (Tm) MetRS. The assays were <br /> enzyme groups MetRS1 form; thus, distinct                         performed twice independently triplicate experiment. <br /> from mammalian cytoplasmic MetRS enzyme. Differences                                 Aminoacylation assays. Enzyme activity quantified attachment of <br /> with human mitochondrial MetRS discussed paper.                       [3H]methionine tRNA presence MetRS enzymes. Reactions were <br />    Synthetic compounds targeting bacterial MetRS enzymes                              performed 96-well filter plates Durapore membranes (MSHVN4B10; <br />                                                                                       Millipore) volumes 75 &#65533;?&#65533;l. The reaction performed 25 mM HEPES, <br /> are advanced preclinical development treating bac-                         pH 7.9, 10 mM MgCl2, 50 mM KCl, 0.2 mM spermine, 0.1 mg/ml bovine serum <br /> terial infections caused methicillin-resistant Staphylococcus                      albumin, 2.5 mM dithiothreitol, 10 U/ml pyrophosphatase (R4251; Sigma). <br /> aureus <span id='am-56' about='obo:NCBITaxon_1485' typeof='owl:Thing obo:NCBITaxon_186802 obo:NCBITaxon_1239 obo:NCBITaxon_1 obo:NCBITaxon_186801 obo:NCBITaxon_131567 obo:NCBITaxon_2 obo:NCBITaxon_31979'><span id='am-57' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-58'  ></span><span id='am-59' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-60' property="rdfs:label" content="Clostridium" datatype="xsd:string"></span>Clostridium</span> difficile (5, 6). These originated diaryl                   Recombinant enzyme (4 nM) compound inhibitors (50 nM) mixed with <br /> diamine compounds development GlaxoSmithKline                                buffer preincubated 15 min. To start reaction, 400 &#65533;?&#65533;g/ml bulk <br />                                                                                       <span id='am-206' about='obo:NCBITaxon_562' typeof='owl:Thing obo:NCBITaxon_561 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_91347 obo:NCBITaxon_1224 obo:NCBITaxon_2 obo:NCBITaxon_543 obo:NCBITaxon_1236'><span id='am-207'  ></span><span id='am-208' property="oboInOwl:hasRelatedSynonym" content="Enterococcus coli" datatype="xsd:string"></span><span id='am-209' property="oboInOwl:hasAlternativeId" content="NCBITaxon:662104" datatype="xsd:string"></span><span id='am-210' property="oboInOwl:hasAlternativeId" content="NCBITaxon:662101" datatype="xsd:string"></span><span id='am-211' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-212' property="oboInOwl:hasRelatedSynonym" content="Escherchia coli" datatype="xsd:string"></span><span id='am-213' property="rdfs:label" content="Escherichia coli" datatype="xsd:string"></span><span id='am-214' property="oboInOwl:hasDbXref" content="PMID:10319482" datatype="xsd:string"></span><span id='am-215' property="oboInOwl:hasRelatedSynonym" content="Bacillus coli" datatype="xsd:string"></span><span id='am-216' property="oboInOwl:hasRelatedSynonym" content="Bacterium coli commune" datatype="xsd:string"></span><span id='am-217' property="oboInOwl:hasRelatedSynonym" content="bacterium E3" datatype="xsd:string"></span><span id='am-218' property="oboInOwl:hasExactSynonym" content="Escherichia/Shigella coli" datatype="xsd:string"></span><span id='am-219' property="oboInOwl:hasRelatedSynonym" content="Eschericia coli" datatype="xsd:string"></span><span id='am-220' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-221' property="oboInOwl:hasRelatedSynonym" content="Bacterium coli" datatype="xsd:string"></span>Escherichia coli</span> tRNA (R4251; Sigma), 0.2 mM ATP, 250 nM [3H]methio- <br /> (10, 15, 16) subsequently Replidyne (6, 13). We                              (80 Ci/mmol) added. The plate incubated shaking room <br /> synthesized compounds relating diaryl diamines                             temperature 120 min. The reactions stopped addition 100 &#65533;?&#65533;l <br /> tested binding recombinant T. brucei MetRS,                           cold 10% trichloroacetic acid. The reaction components separated from <br /> on T. brucei cell cultures, murine model T. brucei                      tRNA filtration vacuum manifold washed times cold <br />                                                                                       10% trichloroacetic acid. The filter plates dried overnight, scintillation fluid <br /> infection. This report includes results molecular <br />                                                                                       added, counts plates determined scintillation plate <br /> modeling studies compounds RNA inter-                             counter. Samples run quadruplicate, average activity inhibitors <br /> ference (RNAi) studies establishing essentiality                           compared control wells inhibitors. <br /> MetRS enzyme T. brucei.                                                               Growth inhibition assays T. brucei, T. cruzi, mammalian cell cultures. <br />                                                                                       T. brucei (bloodstream form strain 427 K. Stuart, Seattle Biomedical Research <br />                                                                                       Institute, Seattle, WA) cultured HMI-9 medium containing 10% fetal bovine <br />                         MATERIALS AND METHODS                                         serum, penicillin, streptomycin 37&#176;C 5% CO2 (14). Drug sensitivity the <br />                                                                                       T. brucei strain determined 96-well microtiter plates triplicate initial <br />    Synthesis diaryl diamines. Synthesis inhibitors followed literature-     inoculum 1 &#11003; 104 trypomastigotes well. Compound stock solutions were <br /> reported route. Briefly, aniline condensed malonic acid phosphorus        prepared DMSO 20 mM added serial dilutions final volume 200 <br /> oxychloride 2,4-dichloroquinoline (24). Subsequently, reaction 4-        &#65533;?&#65533;l/well. Parasite growth quantified 48 h addition AlamarBlue <br /> methoxybenzyl alcohol activated NaH performed dry tetrahydrofuran         (Alamar Biosciences, Sacramento, CA) (25). Pentamidine isethionate (Aventis, <br /> in presence 15-crown-5 produce 2-chloro-4-(4-methoxybenzyloxy)-quin-        Dagenham, United <span id='am-244' about='obo:NCBITaxon_kingdom' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-245' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-246' property="rdfs:label" content="kingdom" datatype="xsd:string"></span>Kingdom</span>) included assay positive control. <br /> oline (16), reacted excess 1,3-diaminopropane N1-[4-(4-        Standard errors assays consistently 15%. <br /> methoxy-benzyloxy)-quinolin-2-yl]-propane-1,3-diamine (15). Deprotection             Compounds screened Tulahuen strain T. cruzi expressing <br /> performed 2:8 trifluoroacetic acid-dichloromethane, condensation        &#65533;?&#65533;-galactosidase 96-well tissue culture plates described previously (2). In this <br /> a variety substituted unsubstituted benzaldehydes reductive amina-        assay, T. cruzi proliferates intracellular amastigotes murine 3T3 fibroblasts. <br /> tion conditions (2.5% acetic acid methanol NaCNBH3) gave final             Compounds screened triplicate determine 50% effective concentrations <br /> compounds, purification (15, 16). The newly synthesized compounds gave          (EC50s). Standard errors assays consistently 15%. <br /> satisfactory analytical <span id='am-257' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-258' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-259' property="rdfs:label" content="Data" datatype="xsd:string"></span><span id='am-260'  ></span><span id='am-261' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>data</span> (details provided supplemental material).      The human lymphocytic cell line CRL-1855 (American Type Culture Collec- <br />    RNA interference. The T. brucei MetRS homolog (Tb927.10.1500)              tion) used cytotoxicity assessment. The cells grown RPMI <br /> target RNAi knockdown experiment. The region bases 994            medium 10% fetal bovine serum, penicillin, streptomycin 37&#176;C with <br /> 1615 open reading frame amplified (primers 1 2 Table S1      5% CO2. Cells (5 &#11003; 103/well) added 96-well plates incubated with <br /> supplemental material) cloned 2T7TABlue (a gift D. Horn, London           serial dilutions compounds 48 h. At time, cell viability quantified <br /> School Hygiene Tropical Medicine) (1). Transfections RNAi exper-           addition AlamarBlue, plates incubated additional 4 h 5% <br /> iments performed previously described (23).                                   CO2, 37&#176;C. Absorbance readings obtained optical density 570 600 nm <br />    Northern analysis. RNA isolated induced noninduced cultures           used calculate viability referenced cells grown inhibitors. <br /> after 72 h growth using Qiagen RNEasy kit (no. 74104). Total RNA (11 &#65533;?&#65533;g             Washout experiments T. brucei cultures. T. brucei cells (strain culture <br /> per lane) separated formaldehyde gel blotted using standard              conditions described above) grown 1.5-ml volumes 12-well plates in <br /> procedures. The RNA membrane analyzed 32P-labeled DNA                 presence compound 2 pentamidine. The concentrations com- <br /> probe region MetRS overlapping portion used         pounds represented factors EC50s determined 48-h incuba- <br /> RNA interference. The probe fragment amplified primers 3 4 (see          tion. At defined times (6, 12, 24, 36, 48 h), cells removed, centrifuged, <br /> Table S1 supplemental material), correspond bases 30 657        washed, resuspended medium compounds. The cultures were <br /> the TbMetRS open reading frame. The blot stripped reprobed               allowed grow 48-h time point exposure com- <br /> DNA T. brucei &#65533;?&#65533;-tubulin gene standardization (see primers 5 6       pounds, time viability cultures assessed using AlamarBlue <br /> Table S1 supplemental material).                                               described above. The viability cells expressed percentage the <br />    PCR ligase-independent cloning. The gene coding T. brucei methionyl-       viability cells grown compounds 48 h. In <span id='am-191' about='obo:NCBITaxon_order' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-192' property="rdfs:label" content="order" datatype="xsd:string"></span><span id='am-193' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>order</span> determine <br /> tRNA synthetase (Tb927.10.1500) amplified T. brucei brucei strain 427        time needed kill parasites, aliquots cultures (plus an <br /> genomic DNA using primers 7 8 (see Table S1 supplemental               additional aliquot taken cells grown compounds 72 h) were <br /> material). The gene coding amino acids 219 765 T. cruzi methionyl-      incubated medium compounds 10 days. The cultures were <br /> tRNA synthetase (Tc00.1047053509247.50) amplified T. cruzi TCCL              inspected light microscopy daily outgrowth living parasites. This gave <br /> Brener genomic DNA primers 9 10 (see Table S1 supplemental            sufficient time outgrowth single surviving parasite, based the <br /> material). The PCR products gel purified Qiagen kit cloned       findings previous experiments. The conditions parasite outgrowth <br /> the AVA0421 vector ligation-independent cloning described previously            observed marked (see Fig. 3). <br /> (21). The AVA0421 vector derivative pET14b vector containing              Pharmacokinetic efficacy studies mice. For pharmacokinetic studies, <br /> N-terminal 6-histidine tag followed 3C protease cleavage site.                   compound 1 dissolved 10% DMSO injected intraperitoneal <br />    Production recombinant T. brucei T. cruzi MetRSs. The expression         (i.p.) route 50 mg/kg body weight BALB/c mice (7- 8-week-old <br /> recombinant proteins performed previously described (21). The N-termi-         females, n &#11005; 3). At timed intervals, 20 &#65533;?&#65533;l tail blood collected hepa- <br /> nal 6-His fusion proteins purified nickel affinity chromatography fol-        rinized capillary tubes. Plasma separated frozen later analysis by <br />  1984       SHIBATA ET AL.                                                                                                 ANTIMICROB. AGENTS CHEMOTHER. <br />  <br /> liquid chromatography-mass spectrometry (28). For efficacy studies, compound 1 <br /> was loaded Alzet minipumps (model 1003D) implanted subcutaneously <br /> into BALB/c mice (7- 8-week-old females, n &#11005; 5 group) delivery 25 <br /> mg/kg/day 3 days. The control group given minipumps loaded with <br /> vehicle. Mice infected T. brucei strain 427 (1 &#11003; 104 i.p.) 1 day prior to <br /> implantation minipumps. Parasitemia quantified blood from <br /> tail bleeding using hemacytometer. Blood levels compound 1 obtained <br /> from mice minipumps place 24 h. Concentrations of <br /> compound 1 analyzed plasma described above. <br />    Homology modeling docking studies. Homology modeling using <br /> the MODELLER software program (19). Docking studies utilized FLO/QXP <br /> docking program Metropolis Monte Carlo scheme (20). Additional details of <br /> building homology model provided supplemental material. <br />  <br />  <br />  <br />                                   RESULTS <br />    Target validation RNA interference. T. brucei amenable <br /> to RNA interference analysis establish essentiality of <br /> gene targets cell viability. Gene knockdown MetRS <br /> (Tb927.10.1500 gene) resulted dramatic growth inhibition <br /> phenotype; day 8, growth inhibited factor &#11011;106 <br /> (Fig. 1). Total RNA collected 72 h, Northern blots <br /> demonstrated MetRS mRNA knocked by <br /> between 57 77% compared level control cells. <br /> Thus, complete knockdown MetRS tran- <br /> script, cell growth profoundly inhibited. <br />    Binding compounds T. brucei MetRS, inhibition of <br /> MetRS enzyme, inhibition trypanosome cell cultures. A <br /> set diaryl diamines (compounds 2, 3, 7) synthe- <br /> sized tested binding recombinant T. brucei MetRS <br />                                                                                          FIG. 1. Growth T. brucei undergoing RNAi MetRS. (Top) <br /> using thermal shift assay (Table 1). The initial set com-                        A region &#11011;500 nucleotides 3&#11032; end gene targeted using <br /> pounds demonstrated large thermal shifts (&#9004;Tm) T.                              p2T7 expression vector (1). RNAi induced (&#11001;) addition of <br /> brucei MetRS, exceeding 7&#176;C. A &#9004;Tm exceeding 2&#176;C usually                           tetracycline medium left uninduced (&#11002;). The growth rate two <br /> considered significant. These compounds tested                          separate clones (MET 1 MET 2) tested compared of <br />                                                                                       single-marker (SM) control, does contain RNAi con- <br /> activity T. brucei cultures remarkable                           struct. Note y <span id='am-183' about='obo:NCBITaxon_9855' typeof='owl:Thing obo:NCBITaxon_9850 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_91561 obo:NCBITaxon_35500 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_34878 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314145 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_9845'><span id='am-184' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-185' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-186' property="rdfs:label" content="Axis" datatype="xsd:string"></span><span id='am-187'  ></span>axis</span> log scale. (Bottom) Northern blots the <br /> potency, particularly compound 2, EC50 8 nM. As                          reduction mRNA levels T. brucei MetRS (TbMetRS) two <br /> result, additional 18 compounds synthesized inves-                         clones induced tetracycline (TCN&#11001;) induced with <br /> tigate structure-activity relationships, particularly focusing                     tetracycline (TCN&#11002;) 72 h. Approximately equivalent loading the <br /> the phenyl ring left scaffold, shown                         samples demonstrated Northern blots constitutively ex- <br />                                                                                       pressed &#65533;?&#65533;-tubulin (Tb&#65533;?&#65533;-Tubulin) mRNA. Densitometry T. brucei <br /> Table 1. By substituting 3,5-bromines 3,5-chlorines                          MetRS mRNA (normalized &#65533;?&#65533;-tubulin) showed 77% 57% signal <br /> (compound 1), activity T. brucei cells                        knockdowns clone 1 clone 2, respectively. <br /> improved EC50 4 nM. The activities 21 compounds <br /> are displayed Table 1. Binding compounds the <br /> recombinant enzyme, measured thermal melting, and <br /> EC50s T. brucei cultures highly correlated (Fig. 2). An                          Washout experiments. In order determine exposure <br /> enzymatic assay developed directly measure                            time required kill T. brucei MetRS inhibitor, T. brucei <br /> aminoacylation activity T. brucei MetRS. The com-                              cultures incubated presence compound 2 or <br /> pounds tested enzyme 50 nM, inhibition                            pentamidine defined time periods transferred to <br /> observed high 99% (compound 1; Table 1). Enzyme                           drug-free medium growth quantification 48 h (Fig. 3A). <br /> inhibition data highly correlated thermal melt                          Incubation compound 2 24 h concentrations 2 times <br /> shifts (R2 &#11005; 0.821, P &#65533;? 0.0001) EC50s T. brucei                       EC50 resulted &#11022;95% growth suppression, indicating that <br /> cultures (R2 &#11005; 0.646, P &#65533;? 0.0001). The compounds did                              relative short exposure times lead profound growth suppres- <br /> inhibit growth mammalian cell line CRL-8155 con-                            sion. However, cultures left incubate 10 <br /> centrations high 20 &#65533;?&#65533;M, indicating large selectivity                     days compound washed out, parasites eventually <br /> index 5,000 (Table 1).                                                  grew conditions, unless cells were <br />    In addition, binding compounds recombinant T.                        exposed 8 times EC50 72 h, 16 times EC50 for <br /> cruzi MetRS inhibition T. cruzi amastigote growth                         48 h, 64 times EC50 36 h (see values marked with <br /> evaluated (Table 1). Again, substantial &#9004;Tm shifts                           asterisks Fig. 3A). For comparison, HAT drug pentam- <br /> 12.0&#176;C observed compounds interacted                               idine completely trypanocidal cultures ex- <br /> enzyme. There potent activity T. cruzi amastigotes,                       posed 8 times EC50 48 h 16 times EC50 36 h <br /> although EC50s higher seen T. brucei                           (Fig. 3B). Thus, MetRS inhibitor slightly rapid <br /> cells factor &#11011;10 40.                                                       pentamidine exerting trypanocidal effects. <br />  VOL. 55, 2011                                                            T. BRUCEI METHIONYL-tRNA SYNTHETASE INHIBITORS                               1985 <br />  <br />  <br />                  TABLE 1. Binding inhibitory activity diaryl diamine compounds MetRS enzymes cell culturesa <br />  <br />  <br />  <br />  <br />                         Substituent ring position:                               % inhibition of <br />                                                                 T. brucei MetRS                       T. brucei   T. cruzi MetRS    T. cruzi    Mammalian <br />                                                                                        T. brucei <br /> Compound                                                          &#9004;Tm &#11006; SEM                             EC50       &#9004;Tm &#11006; SEM         EC50        cell EC50 <br />                                                                                      MetRS 50 <br />                   2            3         4         5       6          (&#176;C)                             (nM)             (&#176;C)         (nM)          (nM) <br />                                                                                      nM &#11006; SEM <br />  <br />       1                      Cl                   Cl              12.9 &#11006; 0.04        99.2 &#11006; 0.09            4      12.0 &#11006; 0.03           175     &#11022;20,000 <br />       2                      Br                   Br              12.9 &#11006; 0.15        98.8 &#11006; 0.18            8      11.3 &#11006; 0.09           310     &#11022;20,000 <br />       3         OOEt         Br                   Br              12.2 &#11006; 0.19        98.2 &#11006; 0.15           30      11.3 &#11006; 0.04           876     &#11022;20,000 <br />       4                      Cl                                    7.7 &#11006; 0.04        97.3 &#11006; 0.05           35       7.9 &#11006; 0.07           842     &#11022;20,000 <br />       5                     OCH3                OCH3               7.8 &#11006; 0.01        91.1 &#11006; 0.97           70       7.5 &#11006; 0.07           452     &#11022;20,000 <br />       6          Cl                              Cl                8.8 &#11006; 0.01        93.1 &#11006; 0.23           73       9.8 &#11006; 0.05           485     &#11022;20,000 <br />       7                       Cl        Cl                        10.1 &#11006; 0.03        91.7 &#11006; 0.94           75       8.7 &#11006; 0.04           830     &#11022;20,000 <br />  <br />       8                       Br                                   7.1 &#11006; 0.06        82.7 &#11006; 4.76           75       7.1 &#11006; 0.04         2,140     &#11022;20,000 <br />       9        Cl             Cl                                   6.9 &#11006; 0.04        77.9 &#11006; 1.42           95       7.7 &#11006; 0.24         1,230     &#11022;20,000 <br />       10      OOCH3           Br                  Br               9.4 &#11006; 0.07        95.0 &#11006; 0.29          100       8.8 &#11006; 0.07           920     &#11022;20,000 <br />       11       Cl                       Cl                         6.1 &#11006; 0.04        87.1 &#11006; 0.96          133       7.3 &#11006; 0.05         1,230     &#11022;20,000 <br />       12                     F                     F               5.6 &#11006; 0.04        45.8 &#11006; 9.22          200       6.4 &#11006; 0.03         1,920     &#11022;20,000 <br />       13                   OOCF3                                   5.5 &#11006; 0.04        56.5 &#11006; 20.5          375       5.5 &#11006; 0.08         2,390     &#11022;20,000 <br />       14         Cl                                       Cl       1.7 &#11006; 0.04        51.3 &#11006; 22.2        1,000       5.1 &#11006; 0.10         4,000     &#11022;20,000 <br />  <br />       15                    OCF3                OCF3               1.1 &#11006; 0.12        36.9 &#11006; 11.0       1,250        3.4 &#11006; 0.05     &#11022;10,000       &#11022;20,000 <br />       16                    OOEt                                   1.6 &#11006; 0.10        19.1 &#11006; 1.96       1,300        3.6 &#11006; 0.03     &#11022;10,000       &#11022;20,000 <br />       17                    OCN                                    1.6 &#11006; 0.04        20.2 &#11006; 2.54       1,500        3.4 &#11006; 0.04     &#11022;10,000       &#11022;20,000 <br />       18                                Cl                         2.2 &#11006; 0.10        52.0 &#11006; 1.13       1,300        5.3 &#11006; 0.07      ND           &#11022;20,000 <br />       19                  OOCH3                OOCH3               1.2 &#11006; 0.10        35.3 &#11006; 9.54       2,000        3.3 &#11006; 0.01     &#11022;10,000       &#11022;20,000 <br />       20         Cl                                                1.8 &#11006; 0.07        31.8 &#11006; 3.55       2,500        4.0 &#11006; 0.05       6,500       &#11022;20,000 <br />       21         H            H         H          H       H       0.9 &#11006; 0.04         9.0 &#11006; 3.34      &#11022;5,000        2.1 &#11006; 0.04     &#11022;10,000       &#11022;10,000 <br />   a <br />    Binding (&#9004;Tm) measured thermal melt method, enzyme inhibition (%) measured aminoacylation assays, cell growth inhibition (EC50) was <br /> measured described Materials Methods. <br />  <br />  <br />    Pharmacokinetic efficacy experiments mice. The                          EC50, compound 1 delivered subcutaneous osmotic mini- <br /> most potent compound, compound 1, subjected single-                      pumps 25 mg/kg/day efficacy experiment. The pumps <br /> dose pharmacokinetic study mice. Following i.p. injec-                      designed deliver compound 3 days. Blood levels the <br /> tion, blood sampled time intervals analyzed                         day implantation measured 0.56 &#11006; 0.12 &#65533;?&#65533;M <br /> liquid chromatography-mass spectrometry. The terminal half-                       (average &#11006; standard error mean [SEM]; n &#11005; 5 mice). In T. <br /> life determined &#11011;1.0 h (data shown). In order                    brucei-infected mice, nearly complete suppression parasitemia <br /> provide sustained blood level mice vitro                   observed microscopic examination blood smears 8 <br />                                                                                   days (Fig. 4). After 8 days, parasitemia evident the <br />                                                                                   mice succumbed infection. Average survival time doubled <br />                                                                                   mice treated compound 1 compared mice <br />                                                                                   treated vehicle (Fig. 4). No apparent effects evi- <br />                                                                                   dent mice treated compound 1 the <br />                                                                                   single-dose pharmacokinetic studies efficacy studies <br />                                                                                   implanted minipumps. <br />                                                                                      Homology modeling ligand docking studies trypano- <br />                                                                                   somatid MetRS enzymes. Due absence crystal <br />                                                                                   structure T. brucei T. cruzi MetRS, homology models <br />                                                                                   created docking studies gain insight bind- <br />                                                                                   ing mode diaryl diamine inhibitors. Three-dimensional <br />                                                                                   structures MetRS 6 <span id='am-188' about='obo:NCBITaxon_species' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-189' property="rdfs:label" content="species" datatype="xsd:string"></span><span id='am-190' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>species</span> available templates <br />                                                                                   homology modeling. The structures Protein Data <br />                                                                                   Bank (PDB) originate <span id='am-76' about='obo:NCBITaxon_2713' typeof='owl:Thing obo:NCBITaxon_187857 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_2 obo:NCBITaxon_64898 obo:NCBITaxon_200783 obo:NCBITaxon_32069'><span id='am-77' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-78'  ></span><span id='am-79' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-80' property="rdfs:label" content="Aquifex" datatype="xsd:string"></span>Aquifex</span> aeolicus, <span id='am-199' about='obo:NCBITaxon_270' typeof='owl:Thing obo:NCBITaxon_188786 obo:NCBITaxon_188787 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_2 obo:NCBITaxon_68933 obo:NCBITaxon_1297'><span id='am-200' property="rdfs:label" content="Thermus" datatype="xsd:string"></span><span id='am-201' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-202' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-203'  ></span><span id='am-204' property="oboInOwl:hasDbXref" content="PMID:5781580" datatype="xsd:string"></span><span id='am-205' property="oboInOwl:hasDbXref" content="PMID:8240955" datatype="xsd:string"></span>Thermus</span> thermo- <br />   FIG. 2. Correlation cell growth inhibition (EC50) binding             <span id='am-247' about='obo:NCBITaxon_583468' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_71528 obo:NCBITaxon_41084 obo:NCBITaxon_33154 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_584324 obo:NCBITaxon_6656 obo:NCBITaxon_41088 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557 obo:NCBITaxon_7041'><span id='am-248' property="rdfs:label" content="Philus" datatype="xsd:string"></span><span id='am-249' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-250' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-251'  ></span>philus</span>, <span id='am-81' about='obo:NCBITaxon_2260' typeof='owl:Thing obo:NCBITaxon_183968 obo:NCBITaxon_1 obo:NCBITaxon_2157 obo:NCBITaxon_131567 obo:NCBITaxon_2259 obo:NCBITaxon_2258 obo:NCBITaxon_28890'><span id='am-82' property="rdfs:label" content="Pyrococcus" datatype="xsd:string"></span><span id='am-83'  ></span><span id='am-84' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-85' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Pyrococcus</span> abyssi, <span id='am-222' about='obo:NCBITaxon_561' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_91347 obo:NCBITaxon_1224 obo:NCBITaxon_2 obo:NCBITaxon_543 obo:NCBITaxon_1236'><span id='am-223' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-224' property="oboInOwl:hasRelatedSynonym" content="Escherchia" datatype="xsd:string"></span><span id='am-225' property="rdfs:label" content="Escherichia" datatype="xsd:string"></span><span id='am-226' property="oboInOwl:hasDbXref" content="PMID:19700542" datatype="xsd:string"></span><span id='am-227' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-228'  ></span>Escherichia</span> coli, <span id='am-61' about='obo:NCBITaxon_1763' typeof='obo:NCBITaxon_85007 owl:Thing obo:NCBITaxon_1762 obo:NCBITaxon_1 obo:NCBITaxon_1760 obo:NCBITaxon_131567 obo:NCBITaxon_2 obo:NCBITaxon_2037 obo:NCBITaxon_201174 obo:NCBITaxon_85003'><span id='am-62' property="oboInOwl:hasDbXref" content="PMID:7547284" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasDbXref" content="PMID:1883713" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasDbXref" content="PMID:16014496" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasDbXref" content="PMID:8863452" datatype="xsd:string"></span><span id='am-66' property="oboInOwl:hasDbXref" content="PMID:7547304" datatype="xsd:string"></span><span id='am-67' property="oboInOwl:hasRelatedSynonym" content="Mycobacterium Lehmann and Neumann 1896" datatype="xsd:string"></span><span id='am-68' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-69' property="oboInOwl:hasDbXref" content="PMID:1380284" datatype="xsd:string"></span><span id='am-70' property="oboInOwl:hasDbXref" content="PMID:2275850" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:hasDbXref" content="PMID:7907223" datatype="xsd:string"></span><span id='am-72' property="rdfs:label" content="Mycobacterium" datatype="xsd:string"></span><span id='am-73'  ></span><span id='am-74' property="oboInOwl:hasDbXref" content="PMID:1581193" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span>Mycobacterium</span> <br /> recombinant parasite MetRS. Binding determined shift                smegmatis. In addition, Medical Structural Genomics of <br /> the melting temperature (&#9004;Tm) protein presence of <br /> compounds. R2 values 0.92 (P &#65533;? 0.0001) T. brucei (solid dia- <br />                                                                                   Pathogenic Protozoa (MSGPP) consortium recently solved the <br /> monds) 0.79 (P &#65533;? 0.0001) T. cruzi (open circles). Numeric data            structure <span id='am-166' about='obo:NCBITaxon_5664' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_38581 obo:NCBITaxon_131567 obo:NCBITaxon_5658 obo:NCBITaxon_33682 obo:NCBITaxon_1286322 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_38568 obo:NCBITaxon_5653'><span id='am-167' property="oboInOwl:hasRelatedSynonym" content="Leishmania tropica major" datatype="xsd:string"></span><span id='am-168' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-169'  ></span><span id='am-170' property="oboInOwl:hasRelatedSynonym" content="Leishmania (Leishmania) major" datatype="xsd:string"></span><span id='am-171' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-172' property="rdfs:label" content="Leishmania major" datatype="xsd:string"></span>Leishmania major</span> enzyme, eukaryotic <br /> for series compounds presented Table 1.                            MetRS structure solved (18). Sequence comparisons of <br />  1986     SHIBATA ET AL.                                                                                     ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br />  <br />  <br />   FIG. 3. Washout experiments T. brucei compound 2 pentamidine. The bar graphs indicate percent growth cultures <br /> compared level growth cultures grown compound. The cultures incubated compound 2 (A) pentamidine <br /> (B) concentrations 2 64 times EC50 (established 48-h experiments) various periods exposure 6 48 h. Below bar <br /> graph, cultures marked asterisk cell growth observed 10 days following washout compound. <br />  <br />  <br />  <br /> the T. cruzi T. brucei MetRS proteins Leish-              Section S1 supplemental material). Upon docking into <br /> mania MetRS homologs PDB showed overall                    homology model, compound 1 binding <br /> amino acid sequence identities ranging 24 60% (see                pockets (Fig. 5). The benzyl fragment occupies methionine <br /> Table S2 supplemental material). A detailed                   pocket <span id='am-229' about='obo:NCBITaxon_94025' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_27394 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_74971 obo:NCBITaxon_74974 obo:NCBITaxon_6854 obo:NCBITaxon_6843 obo:NCBITaxon_74975 obo:NCBITaxon_33154 obo:NCBITaxon_6905 obo:NCBITaxon_6656 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6893 obo:NCBITaxon_6072'><span id='am-230' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-231' property="rdfs:label" content="Meta" datatype="xsd:string"></span><span id='am-232'  ></span><span id='am-233' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>meta</span>-chlorine atoms same <br /> analysis performed compare residues constituting               position sulfur atom methionine. The methio- <br /> the methionine/ATP binding pockets respective en-                  pocket formed 11 residues, are <br /> zymes (see Table S3 supplemental material). The                    hydrophobic. The 2-amino-quinolinone fragment resides a <br /> crystal structure complex E. coli MetRS                second, adjacent pocket engages hydrogen bonds <br /> L-methionyladenylate served reference structure,              nitrogens carboxylate Asp 287 and <br /> the active-site pocket defined residues 5 &#197;              hydrogen bond phenol hydroxyl Tyr 472. <br /> the L-methionyladenylate ligand. The pocket contained 24                  Twelve residues make second pocket. The ali- <br /> residues, identity scores analyzed              phatic linker inhibitor mainly abuts Tyr 250 (Fig. 5). <br /> MetRS enzymes ranged 58 100% (see Table S4                     Comparison sequence human cytosolic enzyme to <br /> the supplemental material). The trypanosomatid or-                  sequences trypanosomatid enzymes reveals 13 dif- <br /> ganisms identical methionine/ATP binding pockets.                     ferences 25 residues predicted contact compound 1 <br />   An homology model T. brucei T. cruzi enzymes                (see Table S5 supplemental material). The human mi- <br /> built using L. major structure, highest se-             tochondrial MetRS predicted differences contact <br /> quence identity, modified conformation                  residues compound 1 compared trypanosomatid <br /> binding site mimic arrangement seen A. aeolicus             enzymes (see Table S5 supplemental material). The <br /> 2CSX structure. That conformational arrangement required               significance similarity human mitochondrial <br /> for inhibition bacterial MetRS diaryl inhibitors (see           MetRS T. brucei MetRS discussed below. <br />  VOL. 55, 2011                                                       T. BRUCEI METHIONYL-tRNA SYNTHETASE INHIBITORS                          1987 <br />  <br />  <br />  <br />  <br />                                                                             FIG. 5. Structural model T. brucei MetRS compound 1 <br />                                                                          docked active site. The dichlorinated benzyl fragment left <br />                                                                          resides methionine substrate pocket, 2-amino-quino- <br />                                                                          linone fragment occupies adjacent pocket right pre- <br />                                                                          dicted interact Asp 287. The protein molecular surface shown <br />                                                                          transparent gray. The atomic color code cyan protein C, yellow <br />                                                                          ligand C, blue N, red O, purple Cl. <br />  <br />  <br />  <br />                                                                          zyme essential trypanosome growth. The RNA inter- <br />    FIG. 4. Efficacy compound 1 mouse model acute T.         ference method used knock mRNA levels the <br /> brucei infection. Mice (n &#11005; 5 group) infected blood-       single MetRS gene identified T. brucei genome. The <br /> stream forms T. brucei day 0. On day 1, subcutaneous Alzet <br /> minipumps delivered compound 1 (25 mg/kg/day) vehicle 3 <br />                                                                          observed RNAi results (Fig. 1) confirmed expectation that <br /> days implanted. Parasitemia (upper panel) rapidly rose       MetRS T. brucei critical normal growth protein <br /> vehicle group, mice euthanized day 4. In        synthesis obviously dependent minimum levels charged <br /> contrast, 4 5 mice treated compound 1 dramatic           tRNAMet. Cell growth inhibited factor 106; how- <br /> suppression parasitemia gradually rebounded 7 8     ever, complete killing detected, possibly the <br /> days postinfection. They survived twice long the <br /> vehicle-treated mice (lower panel). Similar results observed   RNAi method resulted incomplete knockdown the <br /> second experiment (data shown).                                      MetRS transcript 57 77% normal levels two <br />                                                                          clones. <br />                                                                             Three compounds (compounds 2, 3, 7) synthesized <br />                           DISCUSSION                                     basis published reports MetRS inhibitors had <br />                                                                          antibacterial activity (15, 16). These compounds first <br />    tRNA synthetases established targets antimicrobial            tested T. brucei cultures observed remarkably <br /> chemotherapy, foremost example bacterial <span id='am-252' about='obo:NCBITaxon_238707' typeof='owl:Thing obo:NCBITaxon_186623 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_186625 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_123369 obo:NCBITaxon_33154 obo:NCBITaxon_1489908 obo:NCBITaxon_123367 obo:NCBITaxon_123368 obo:NCBITaxon_123365 obo:NCBITaxon_123366 obo:NCBITaxon_1489872 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_1489388 obo:NCBITaxon_1489341 obo:NCBITaxon_7776 obo:NCBITaxon_1489913 obo:NCBITaxon_8075 obo:NCBITaxon_7898 obo:NCBITaxon_32443 obo:NCBITaxon_41665 obo:NCBITaxon_1489917'><span id='am-253' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-254' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-255' property="rdfs:label" content="Iso" datatype="xsd:string"></span><span id='am-256'  ></span>iso</span>-              potent activity, EC50s 8, 30, 75 nM, respectively <br /> leucyl-tRNA synthetase, molecular target mupir-          (Table 1). In order determine compounds bound to <br /> ocin, antibiotic used topically treatment bacterial        T. brucei MetRS enzyme, thermal melt assay using <br /> infections, including <span id='am-14' about='obo:NCBITaxon_1280' typeof='obo:NCBITaxon_91061 owl:Thing obo:NCBITaxon_1385 obo:NCBITaxon_90964 obo:NCBITaxon_1239 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_2 obo:NCBITaxon_1279'><span id='am-15' property="oboInOwl:hasRelatedSynonym" content="Staphylococus aureus" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasRelatedSynonym" content="Staphlococcus pyogenes citreus" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasAlternativeId" content="NCBITaxon:325213" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasRelatedSynonym" content="Staphilococcus aureus" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-21'  ></span><span id='am-22' property="oboInOwl:hasRelatedSynonym" content="Micrococcus aureus" datatype="xsd:string"></span><span id='am-23' property="rdfs:label" content="Staphylococcus aureus" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasRelatedSynonym" content="Micrococcus pyogenes" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasDbXref" content="PMID:8573498" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasRelatedSynonym" content="Staphylococcus pyogenes aureus" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasRelatedSynonym" content="Streptococcus aureus" datatype="xsd:string"></span>Staphylococcus aureus</span> infections. This             recombinant enzyme employed. Pronounced shifts melt- <br /> precedent indicated potential developing selective         ing temperatures observed (&#9004;Tms, 12.9, 12.2, 10.1&#176;C, <br /> inhibitors aaRS enzymes infectious pathogens           respectively). Generally, temperature shifts exceeding 2&#176;C are <br /> as trypanosomes. The MetRS enzyme particularly attrac-             considered significant; thus, data indicated com- <br /> tive target piggyback drug development neglected trop-           pounds tightly bound recombinant MetRS enzyme. <br /> ical diseases (9) existence potent MetRS               With encouraging results, additional 18 compounds <br /> inhibitors development Pharma indications             synthesized explore structure-activity relation- <br /> (22). The similarities bacterial MetRS enzymes               ships, primarily focusing phenyl group left of <br /> and T. brucei T. cruzi led hypothesis       molecule (Table 1). The compound series resulted a <br /> existing compounds bind trypanosomal MetRS enzymes                 broad range activities T. brucei cultures the <br /> and rise antitrypanosomal activity.                              active compound, compound 1, EC50 4 nM, to <br />    Before activity compounds investigated, genetic            active compound, compound 21, EC50 of <br /> experiments conducted establish MetRS en-               &#11022;5,000 nM. All compounds tested thermal <br />  1988     SHIBATA ET AL.                                                                                 ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br /> melt assay, correlation &#9004;Tm EC50 was <br /> plotted (Fig. 2, upper line). A high correlation ob- <br /> served (R2 &#11005; 0.92), meaning compounds bind the <br /> enzyme highest affinity potent inhib- <br /> iting T. brucei cell growth. This evidence com- <br /> pounds act parasites inhibition target <br /> enzyme off-target mechanism. <br />    The compounds tested major <br /> trypanosome pathogen, T. cruzi, observed to <br /> have potent growth inhibition activity (Table 1). There a <br /> high correlation compounds active T. <br /> brucei T. cruzi, expected 100% se- <br /> quence identity predicted inhibitor binding sites (see <br /> Table S4 supplemental material). The EC50s T. <br /> cruzi generally higher (by factor 10 40) those <br /> observed T. brucei. Since T. cruzi amastigotes grown <br /> intracellularly mammalian 3T3 fibroblasts, higher ob- <br />                                                                        FIG. 6. Structures MetRS inhibitors clinical trials bacterial <br /> served EC50s suggest compounds partially            infections (5, 6, 25). <br /> excluded intracellular environment host cells. <br /> Experiments binding compounds recombinant T. <br /> cruzi MetRS yielded results similar observed with <br /> the T. brucei MetRS enzyme. As before, binding affinity         leading irreversible growth arrest similar of <br /> (&#9004;Tm) cell growth inhibition (EC50) highly correlated      pentamidine, drug clinical use early-stage HAT. Thus, <br /> (Fig. 2, line).                                              sustained inhibition MetRS completely kills T. brucei grown in <br />    In order establish binding recombinant T.         vitro. This trypanocidal activity necessary feature the <br /> brucei MetRS related inhibition enzymatic func-       drug used late-stage HAT, drugs completely <br /> tion, aminoacylation assay adopted T. brucei         kill parasites needed clear infection central ner- <br /> enzyme. The method assesses complete enzyme reaction         vous cerebrospinal fluid. <br /> measuring incorporation [3H]methionine tRNA            Compound 1 short plasma half-life mice (&#11011;1 h). For <br /> substrate. The potent compound, compound 1, inhibited          purposes studies, able attain adequate <br /> the enzyme 99.2% 50 nM, suggesting 50% in-           plasma concentrations compound mice adminis- <br /> hibitory concentration (IC50) 50 nM,         tering continuous infusion using osmotic minipumps. <br /> consistent low EC50 4 nM observed T. brucei          Plasma concentrations &#11011;0.5 &#65533;?&#65533;M measured mice <br /> cells. An exact IC50 (possibly subnanomolar) highly         receiving minipumps. Using pumps designed deliver <br /> potent compounds determined en-             compound 3 days, profound suppression parasitemia was <br /> zyme concentration 4 nM necessary robust           observed. However, parasites completely eradi- <br /> signal assay. The correlation enzyme inhibitory      cated, delayed recrudescence parasitemia at <br /> activity thermal melt results tight (R2 &#11005; 0.821,   day 7 8 mice succumbed infection. <br /> P &#65533;? 0.0001) supports use thermal method       There longer survival treated group (&#11011;9 10 <br /> an enzyme assay developed optimized (17).              days) controls (4 days). These data indicate com- <br />    The effect MetRS inhibitors growth mam-         pound 1 profound effect suppress parasitemia and <br /> malian lymphocytic cell line CRL-8155 assessed. Since      prolong survival mice. It suggests higher <br /> no inhibition growth observed 20 &#65533;?&#65533;M        blood levels longer exposure compound 1 required <br /> compounds, indicated remarkably high selectivity index       cures. Since plasma levels &#11011;100 times higher the <br /> for parasites mammalian cells. The molecular mod-          EC50 (4 nM), expected complete clearance of <br /> eling provides explanation compounds            parasites basis results washout exper- <br /> unlikely bind human cytoplasmic MetRS enzyme (see            iments described above. However, factors, pro- <br /> Table S4 supplemental material). However, differ-        tein binding access parasites sequestered tissues out- <br /> ences trypanosomatid MetRS human                blood compartment, reasons complete <br /> mitochondrial MetRS pronounced (see Table S4        cures observed. <br /> supplemental material) (discussed below). These data establish         The analysis amino acids form predicted <br /> the potential selectively inhibit trypanosomatid MetRS       binding site diaryl diamine compounds allowed comparisons <br /> and inhibit trypanosome growth avoiding toxicity           trypanosomatid human MetRS enzymes <br /> mammalian cells.                                                    (see Table S5 supplemental material). Substantial dif- <br />    In vitro washout experiments conducted determine     ferences trypanosomatid human cytosolic <br /> time required compound 2 lead irreversible death   MetRS enzymes observed; specifically, 13 25 residues <br /> parasites. When bloodstream forms T. brucei exposed      different, suggesting inhibitor un- <br /> compound 2 8 times EC50 72 h, parasites did      likely bind tightly pocket enzymes. This fits <br /> recover. Similarly, exposed compound 2 16      published data diaryl diamine REP8839 (Fig. 6) <br /> times EC50 48 h, failed recover. The conditions     essentially inactive human cytosolic enzyme, Ki <br />  VOL. 55, 2011                                                             T. BRUCEI METHIONYL-tRNA SYNTHETASE INHIBITORS                                     1989 <br />  <br />  <br /> being &#11022;20,000 nM (12). Fewer differences inhibitor                       2. Buckner, F. S., C. L. M. J. Verlinde, A. C. La Flamme, W. C. Van <br />                                                                                    Voorhis. 1996. Efficient technique screening drugs activity against <br /> binding site observed trypanosomatid hu-                          <span id='am-149' about='obo:NCBITaxon_5693' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_5690 obo:NCBITaxon_2759 obo:NCBITaxon_47570 obo:NCBITaxon_5653'><span id='am-150' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-151'  ></span><span id='am-152' property="rdfs:label" content="Trypanosoma cruzi" datatype="xsd:string"></span><span id='am-153' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Trypanosoma cruzi</span> using parasites expressing &#65533;?&#65533;-galactosidase. Antimicrob. <br /> man mitochondrial MetRS enzymes, 5 25 residues                        Agents Chemother. 40:2592&#8211;2597. <br /> being different. This fits published data REP8839                3. Charriere, F., S. Helgadottir, E. K. Horn, D. Soll, A. Schneider. 2006. <br />                                                                                    Dual targeting single tRNA(Trp) requires different tryptophanyl- <br /> inhibits human mitochondrial enzyme Ki 10 nM                         tRNA synthetases Trypanosoma brucei. Proc. Natl. Acad. Sci. U. S. A. <br /> (12). Of note, REP8839 inhibits S. aureus MetRS Ki                      103:6847&#8211;6852. <br /> of 10 pM (12), suggesting extremely tight binding pos-                  4. Charriere, F., et al. 2009. Dual targeting tRNA ASP requires two <br />                                                                                    different aspartyl-tRNA synthetases Trypanosoma brucei. J. Biol. Chem. <br /> sible. Unfortunately, know Kis diaryl diamines                    284:16210&#8211;16217. <br /> against trypanosomatid enzymes methods                      5. Critchley, I. A., et al. 2009. Spectrum activity mode action of <br /> accurately measuring Kis highly active compounds                            REP3123, new antibiotic treat Clostridium difficile infections. J. Anti- <br />                                                                                    microb. Chemother. 63:954&#8211;963. <br /> against MetRS (involving adaptation ATP-PPi ex- <br />                                                                                 6. Critchley, I. A., et al. 2005. Antibacterial activity REP8839, new antibi- <br /> change assay [12]) developed trypano-                        otic topical use. Antimicrob. Agents Chemother. 49:4247&#8211;4252. <br /> somatid enzymes. If Ki trypanosomatid MetRS                      7. Crowther, G. J., et al. 2009. Buffer optimization thermal melt assays of <br /> low (&#65533;?&#65533;?1 nM), possible greater activity                 <span id='am-173' about='obo:NCBITaxon_5820' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_5794 obo:NCBITaxon_131567 obo:NCBITaxon_422676 obo:NCBITaxon_2759 obo:NCBITaxon_5819 obo:NCBITaxon_33630'><span id='am-174' property="rdfs:label" content="Plasmodium" datatype="xsd:string"></span><span id='am-175' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-176'  ></span><span id='am-177' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Plasmodium</span> proteins detection small-molecule ligands. J. Biomol. <br />                                                                                    Screen. 14:700&#8211;707. <br /> diaryl diamines trypanosomatid cells mammalian cells                    8. Espanol, Y., D. Thut, A. Schneider, L. R. Pouplana. 2009. A mech- <br /> (Table 1) selective activity trypanosomatid                       anism functional segregation mitochondrial cytosolic genetic <br /> enzyme. However, likely factors                      codes. Proc. Natl. Acad. Sci. U. S. A. 106:19420&#8211;19425. <br />                                                                                 9. Gelb, M. H., et al. 2003. Protein farnesyl N-myristoyl transferases: piggy- <br /> contributing lack toxicity diaryl diamines                        medicinal chemistry targets development antitrypanosomatid <br /> against mammalian cells live animals. One possibility                       antimalarial therapeutics. Mol. Biochem. Parasitol. 126:155&#8211;163. <br /> that compounds penetrate mammalian cells                      10. Gentry, D. R., et al. 2003. Variable sensitivity bacterial methionyl-tRNA <br />                                                                                    synthetase inhibitors reveals subpopulations <span id='am-39' about='obo:NCBITaxon_1313' typeof='obo:NCBITaxon_91061 owl:Thing obo:NCBITaxon_1301 obo:NCBITaxon_1239 obo:NCBITaxon_1 obo:NCBITaxon_1300 obo:NCBITaxon_131567 obo:NCBITaxon_2 obo:NCBITaxon_186826'><span id='am-40'  ></span><span id='am-41' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasRelatedSynonym" content="Micrococcus pneumoniae" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasRelatedSynonym" content="Diplococcus pneumoniae" datatype="xsd:string"></span><span id='am-45' property="rdfs:label" content="Streptococcus pneumoniae" datatype="xsd:string"></span>Streptococcus pneumoniae</span> <br /> as trypanosomatid cells. The observation                      distinct methionyl-tRNA synthetase genes. Antimicrob. Agents <br /> that T. cruzi (grown inside mammalian fibroblasts) EC50s                       Chemother. 47:1784&#8211;1789. <br /> as 44-fold higher T. brucei (grown                   11. Giaever, G., et al. 2002. Functional profiling <span id='am-125' about='obo:NCBITaxon_4932' typeof='owl:Thing obo:NCBITaxon_4930 obo:NCBITaxon_1 obo:NCBITaxon_4751 obo:NCBITaxon_131567 obo:NCBITaxon_4893 obo:NCBITaxon_33154 obo:NCBITaxon_451864 obo:NCBITaxon_4892 obo:NCBITaxon_4891 obo:NCBITaxon_4890 obo:NCBITaxon_716545 obo:NCBITaxon_147537 obo:NCBITaxon_2759'><span id='am-126' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces capensis" datatype="xsd:string"></span><span id='am-127' property="oboInOwl:hasRelatedSynonym" content="Saccaromyces cerevisiae" datatype="xsd:string"></span><span id='am-128' property="oboInOwl:hasRelatedSynonym" content="Candida robusta" datatype="xsd:string"></span><span id='am-129' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-130' property="oboInOwl:hasExactSynonym" content="brewer&apos;s yeast" datatype="xsd:string"></span><span id='am-131' property="oboInOwl:hasExactSynonym" content="yeast" datatype="xsd:string"></span><span id='am-132' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces oviformis" datatype="xsd:string"></span><span id='am-133' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces uvarum var. melibiosus" datatype="xsd:string"></span><span id='am-134' property="oboInOwl:hasExactSynonym" content="lager beer yeast" datatype="xsd:string"></span><span id='am-135' property="rdfs:label" content="Saccharomyces cerevisiae" datatype="xsd:string"></span><span id='am-136' property="oboInOwl:hasRelatedSynonym" content="Sccharomyces cerevisiae" datatype="xsd:string"></span><span id='am-137' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-138' property="oboInOwl:hasExactSynonym" content="baker&apos;s yeast" datatype="xsd:string"></span><span id='am-139' property="oboInOwl:hasRelatedSynonym" content="Saccharomyes cerevisiae" datatype="xsd:string"></span><span id='am-140'  ></span><span id='am-141' property="oboInOwl:hasRelatedSynonym" content="Saccharomyces italicus" datatype="xsd:string"></span>Saccharomyces cerevisiae</span> <br />                                                                                    genome. Nature 418:387&#8211;391. <br /> axenic culture), despite having identical binding pockets               12. Green, L. S., et al. 2009. Inhibition methionyl-tRNA synthetase by <br /> MetRS enzyme (see Table S4 supplemental material),                          REP8839 effects resistance mutations enzyme activity. Antimicrob. <br /> suggests compounds efficiently penetrate                       Agents Chemother. 53:86&#8211;94. <br />                                                                                13. Guiles, J., I. Critchley, X. Sun. 2008. New agents Clostridium diffi- <br /> mammalian cell membrane. It little com-                      cile-associated disease. Expert Opin. Invest. Drugs 17:1671&#8211;1683. <br /> pound passes second barrier (the mitochondrial                     14. Hirumi, H., K. Hirumi. 1989. Continuous cultivation Trypanosoma <br /> membrane) mitochondrial MetRS significantly                        brucei blood stream forms medium containing low concentration of <br />                                                                                    serum protein feeder cell layers. J. Parasitol. 75:985&#8211;989. <br /> inhibited. As new compounds alter pharma-                      15. Jarvest, R. L., et al. 2002. Nanomolar inhibitors Staphylococcus aureus <br /> cological properties, changes affect permeability                    methionyl tRNA synthetase potent antibacterial activity gram- <br /> properties. As result, important carefully test                positive pathogens. J. Med. Chem. 45:1959&#8211;1962. <br />                          <br /> </body></html>